SHORE-C

The use of patient reported outcome measures in routine cancer clinical care: results from a freedom of information request - Discover Health Systems Purpose Patient reported outcome measures (PROMs) are an effective method for monitoring cancer patients from diagnosis. We aimed to identify which NHS trusts in England are using PROMs in routine can...

SHORE-C researchers Sally Wheelwright, Val Shilling and Qi Ying Lean have published a new article in Discover Health Systems! You can read this article here:
doi.org/10.1007/s442...
@sallywheelwright.bsky.social

Researcher Sally Wheelwright presenting at the EORTC in Barcelona

Principal Research Fellow Sally Wheelwright is a speaker and conference co-chair at the 6th EORTC Quality of Life in Cancer Clinical Trials Conference! She will be chairing and speaking at this Barcelona conference over the 12th and 13th May. Good luck to @sallywheelwright.bsky.social!

Incidence and management of diarrhoea associated with abemaciclib and endocrine therapy for hormone-receptor positive, HER2-negative metastatic breast cancer: the UK patients’ experiences - Supportive... Purpose Addition of a CDK4/6 inhibitor to endocrine therapy (ET) prolongs survival in HR + /HER2-metastatic breast cancer (MBC). Gastrointestinal side effects, predominantly diarrhoea and abdominal pa...

SHORE-C have two papers in the new edition of Springer's Supportive Care in Cancer journal! Congratulations to the authors @drhelenaharder.bsky.social, Rachel Starkings, @lfallowfield.bsky.social, Valerie Shilling and Shirley May.
doi.org/10.1007/s005...
doi.org/10.1007/s005...

Integrative Strategies in Palliative Care for MBC The experts discuss integrative models in palliative care for MBC, highlighting the importance of multidisciplinary collaboration and personalized care strategies tailored to the individual’s needs.

SHORE-C's director Prof Dame Lesley Fallowfield has provided video commentary for Medscape's "Transforming Treatment Pathways: Integrative Strategies in Palliative Care for Metastatic Breast Cancer" Please see the below link:
www.medscape.com/viewarticle/...

World psycho-oncology day logo

Today is the inaugural World Psycho-Oncology Day! Researchers from SHORE-C have been working in Psycho-Oncology since the 1980s and we hope this international recognition will lead to greater awareness of the need for psychosocial support in cancer care and the progress made in the last 40 years.

@sallywheelwright.bsky.social has a new article out today! You can read "Flexibility in patient-reported outcome and health-related quality of life measurement: The EORTC Quality of Life Group measurement strategy" at the link below:
doi.org/10.1016/j.ej...

Dr Valerie Shilling presenting her poster at the BPOS conference

Researchers Dr Valerie Shilling and Rachel Starkings attended the BPOS 2025 Annual Conference this March. They presented a poster on their pilot study "Navigating Angry Conversations". For more information please see our website at shore-c.sussex.ac.uk/news.php

SHORE-C Researcher Sally Wheelwright at the EORTC 2025 Spring Meeting in Rotterdam

SHORE-C's Principal Research Fellow Sally Wheelwright attended the EORTC Quality of Life Group meeting in Rotterdam 27th-28th March along with over 200 colleagues from across the globe. She presented findings from her EORTC-funded project to develop a curriculum for quality of life in oncology.

SHORE-C's research team are busy this week presenting at both the EORTC Quality of Life Group Spring Meeting 2025 and the British Psychosocial Oncology Society annual conference! Wishing safe travels for Dr Sally Wheelwright (@sallywheelwright.bsky.social), Dr Valerie Shilling and Rachel Starkings!

SHORE-C's Deputy Director Val Jenkins is one of the authors on this new paper: Sexual dysfunction in prostate cancer patients according to disease stage and treatment modality.
You can read this at the link below!
doi.org/10.1016/j.cl...

Uptake, utility and resource requirements of a genetic counselling telephone helpline within the BRCA-DIRECT digital pathway for mainstreamed BRCA testing in patients with breast cancer Background We trialled the first digital pathway (BRCA-DIRECT) aiming to improve capacity for mainstreamed BRCA testing within UK breast oncology services. Patients received standardised digital prete...

Director Lesley Fallowfield has a new article available to read on JMG now!
Titled: Uptake, utility and resource requirements of a genetic counselling telephone helpline within the BRCA-DIRECT digital pathway for mainstreamed BRCA testing in patients with breast cancer: jmg.bmj.com/content/earl...

Improving patient understanding of GEP test results (IMPARTER4): an RCT Objective Explaining gene expression profiling (GEP) test results to patients can be challenging. We examined the utility of two 8 min films about Oncotype DX and Prosigna to aid the knowledge and dec...

SHORE-C has published a new article!
Improving patient understanding of GEP test results (IMPARTER4): an RCT, can be found online at this link:
bmjoncology.bmj.com/content/4/1/...

Read our new article about why ePROMs should be in England's National Cancer Plan authors.elsevier.com/a/1klhP7tJED... You have until the end of April to respond to the call for evidence www.gov.uk/government/c...

SHORE-C is happy to join BlueSky. For more information about us and our research, see our website - shore-c.sussex.ac.uk